InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-0.3%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Sheridan William P, Directeur Médical. Insider active across 1 company, notably Biocryst Pharmaceuticals INC. Cumulatively, 7 reports have been logged. History available since 27 May 2021. The latest transaction was filed on 10 March 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
148,302 shares@ US$3.220.026% mcap69.0% of flowCommon StockSEC:0001127602-22-009124:0
35,000 shares0Common StockSEC:0001127602-21-031118:0
35,000 shares0Common StockSEC:0001127602-21-031118
24,959 shares@ US$4.7315.5% of flowCommon StockSEC:0001127602-21-018509
24,959 shares@ US$4.730.0058% mcap15.5% of flowCommon StockSEC:0001127602-21-018509:0
5,359 sharesCommon StockSEC:0001127602-16-037576:0
2,081 sharesCommon StockSEC:0001127602-16-035655:0
7 of 7 declarations
About Sheridan William P
William P. Sheridan is the Chief Medical Officer at BIOCRYST PHARMACEUTICALS INC. In this role, he is responsible for the company's medical strategy and product development. BIOCRYST PHARMACEUTICALS INC is an innovation-driven biopharmaceutical company. William P. Sheridan brings valuable medical expertise to guide research and development initiatives.
